An international study published in the journal BMC Pulmonary Medicine, involving 1,519 adults, found no clinically significant respiratory differences between exclusive e-cigarette users and non-smokers.
The international research, published in the journal BMC Pulmonary Medicine, was conducted with 1,519 adults across six regions of the world. The study assessed and compared the respiratory symptoms of three groups: exclusive e-cigarette users who have never smoked, non-smokers with no history of smoking, and regular smokers.
During the analysis of the data, experts found no clinically significant difference between the respiratory complaints of exclusive vapers and non-smokers. Although vapers reported slightly more symptoms compared to non-smokers, this difference did not exceed the level of clinical significance.
According to the stated limitations, the study was restricted to reported and clinically assessed complaints and did not take into account biological markers or tissue changes. Furthermore, the results do not imply that the products are absolutely risk-free, and the long-term consequences of e-cigarette use spanning several decades are not yet known due to the limitations of the study’s timeframe.
In brief
- Data from 1,519 adults from six different regions were analyzed in the BMC Pulmonary Medicine study.
- No clinically significant difference was found between the respiratory symptoms of never-smoking vapers and non-smokers.
- Exclusive e-cigarette users reported slightly more symptoms, but the difference remained below the clinical threshold.
- The study did not cover biological markers or long-term effects spanning decades.
Source: Vapoteurs (vapoteurs.net)
This summary was prepared by artificial intelligence based on the original article.